Evolving Horizons in Antibody-Drug Conjugate Innovation

added blog Health

2025-12-08 15:58:12

Antibody-drug conjugates (ADCs) have reshaped modern oncology by combining the selective targeting of monoclonal antibodies with the powerful cancer-killing ability of small-molecule drugs. This approach allows therapy to be delivered directly to malignant cells, limiting harm to surrounding healthy tissue. As research advances, the Antibody Drug Conjugate Market continues to expand, supported...

0 Comments 0 Shares 166 Views 0 Reviews